Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/1/59
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhan B Aen_US
dc.date.accessioned2017-01-30T08:15:50Z-
dc.date.available2017-01-30T08:15:50Z-
dc.identifier.urihttp://hdl.handle.net/123456789/175152-
dc.identifier.urihttp://localhost:8080/xmlui/handle/1/59-
dc.description.abstractSearle examined the loans involved in the flotation of new shares. This particular case examines a local company which had recently acquired a multinational status and then wished to make a private placement at a substantial premium. The case looks at the role of the regulatory authorities, the mechanisms of capital restructuring, and the implication for shareholders.en_US
dc.publisherYESen_US
dc.subjectPharmaceuticals-
dc.subject.classificationFinanceen_US
dc.subject.otherCapital structure, pharmaceuticals, valuation, stock issues, government regulationsen_US
dc.titleSEARLE PAKISTAN (PRIVATE) LIMITEDen_US
dc.type02-414-95-1en_US
dc.locationCase Research Centreen_US
Appears in Collections:Business Case Studies

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.